Company Filing History:
1 out of 6 
1 out of 15 Years Active: 2010-2022
Title: Inventor Arnulf Kletzin: Pioneering Innovations in Biotechnology
Introduction
Arnulf Kletzin, located in Darmstadt, Germany, has made significant contributions to the field of biotechnology, holding two notable patents. His innovative work focuses on various aspects of nucleic acid manipulation and the classification of specific species.
Latest Patents
Kletzin's latest patents include a novel species of genus identified as BR11571, which has been assigned the Accession Deposit Number DSM 32538. This patent aims to enhance the understanding and utilization of genetic materials. Additionally, he has developed a device for the isolation and purification of nucleic acid molecules. This device is designed to effectively bind and inactivate inhibitors of the reagents or enzymes used for DNA manipulation, allowing for the separation of nucleic acid molecules based on their size. His method for isolation also includes the generation of gene libraries from nucleic acid molecules that represent metagenomic data from specific habitats.
Career Highlights
Throughout his career, Arnulf Kletzin has worked with prominent companies in the biotechnology sector, including Brain AG and the Biotechnology Research and Information Network AG. His expertise in the field has allowed him to contribute to crucial breakthroughs in genetic research and applications.
Collaborations
Kletzin's work often involves collaboration with notable colleagues such as Esther Gabor and Renate Schulze. Their combined efforts highlight the importance of teamwork in advancing scientific research and developing innovative solutions within the biotechnology landscape.
Conclusion
Arnulf Kletzin's contributions to biotechnology through his patents exemplify the vital role that innovation plays in advancing science. His work in nucleic acid manipulation not only pushes the boundaries of genetic research but also opens new avenues for practical applications in various fields.